FERRING PHARMACEUTICALS & Design — 1806166
Numéro de demande
1806166
Numéro d'enregistrement
TMA1003671
Type(s)
Dessin
Catégorie
Marque de commerce
Statut de l'OPIC
REGISTERED
Statut de TM5
ACTIF/ENREGISTREMENT/
émit et actif
La demande de marque a été enregistrée auprès de l’Office.
Produite
2016-10-25
Enregistrée
2018-08-27
Date d’expiration de l’enregistrement
2033-08-27
Propriétaire inscrit
FERRING B.V.
Polarisavenue 144
2132 JX Hoofddorp
PAYS-BAS
Agent
CASSELS BROCK & BLACKWELL LLP
Suite 3200, Bay Adelaide Centre - North Tower
40 Temperance St.
Toronto,
ONTARIO M5H0B4
Documents
Rubriques d'index
- FERRING PHARMACEUTICALS
Information sur les codes de Viennes (Code & Description)
- 25.5.2
- Fonds partagés en deux dans le sens horizontal
- 26.4.2
- Rectangles
- A 26.4.5
- Un quadrilatère
- 26.4.9
- Plusieurs quadrilatères, juxtaposés, accolés ou se coupant
- A 26.4.18
- Quadrilatères contenant une ou plusieurs lettres
Produits (Classe de Nice & Énoncé(s))
- 5
- (1) Pharmaceutical preparation that modulates fertility and for use in the induction and stimulation of ovulation in humans in injectable form; pharmaceutical preparations for use as a laxative, bowel cleanser and diagnostic aid in powder form
- 5
- (2) Pharmaceutical preparations and substances in intravenous form for the prevention of premature labour and premature birth; Pharmaceutical preparations for human and animal use in tablet, nasal spray and injectable form which regulate the flow of urine and controls the body's water balance and in injectable form for blood clotting; Pharmaceutical preparation for the treatment of intestinal bowel diseases and certain auto-immune diseases in tablet, enema and suppository form; Brain peptide in injectable form which modulates the pituitary function; Human and animal pharmaceutical preparation used as a vasoconstrictor and in the control of water metabolism in injectable form; Hypothalmic releasing substance for use in human and veterinary medicine as a diagnostic and therapeutic agent; Pharmaceutical preparation consisting of gonadotropin releasing hormones for human and animal use; Pharmaceutical preparations in liquid form for the treatment of hypercalcemia; Pharmaceutical preparation for human and animal use in liquid and nasal spray form which regulates the body's coagulation system; Pharmaceutical preparations, namely a pessary for cervical ripening and induction of labour at term; Pharmaceuticals, namely hormones for treating reproductive and excretory function disorders, X-ray contrast media and gastrointestinal medicaments
- 5
- (3) Pharmaceutical preparations for human use which regulate uterine contractions in injectable form
- 10
- (4) Medical devices for administering hormones, namely infusion pumps, digital timers, and ampules for use with syringes
Services (Classe de Nice & Énoncé(s))
- 42
- (1) Research and development of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; design and development of computer hardware and software; medical research services
Revendication(s)
- Used in CANADA since at least as early as 2006 on goods (1)
- Used in CANADA since at least as early as 2000 on goods (2), (4) and on services
- Used in CANADA since at least as early as 2001 on goods (3)
Historique des actions
| Action | Date de l'action | Date d'échéance | Commentaires |
|---|---|---|---|
| Produite | 2016-10-25 | ||
| Créé | 2016-10-25 | ||
| Formalisée | 2016-10-26 | ||
| Recherche enregistrée | 2017-07-06 | ||
| Premier rapport de l'examinateur | 2017-07-06 | 2018-01-06 | |
| Correspondance créée | 2017-07-25 | 2018-01-25 | |
| Avis d'approbation envoyé | 2018-02-01 | 2018-03-01 | |
| Approuvée | 2018-03-22 | APPROVED BY PROGRAM EX200M1 | |
| Publiée | 2018-04-11 | Vol.65 Issue 3311 | |
| Admise | 2018-07-27 | ||
| Avis d'admission envoyé | 2018-07-27 | 2019-01-27 | |
| Enregistrée | 2018-08-27 | 2033-08-27 | |
| Changement d'agent | 2024-10-04 | From/De: 2502 To/A: 7637 |